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Introduction. The objective of this study was to evaluate the impact of microbial invasion of the amniotic cavity and the type of microorganisms on pregnancy and short-term neonatal outcomes in women with preterm labor. Material and methods. Prospective observational cohort study including women with preterm labor from 22.0 to 36.0 weeks. Microbial invasion of the amniotic cavity was defined based on amniotic fluid aerobic/anaerobic/ mycoplasma cultures, and intra-amniotic inflammation on amniotic fluid interleukin-6 levels. Demographic data and pregnancy outcomes were compared among women exposed to microbial invasion of the amniotic cavity by Ureaplasma spp., women with microbial invasion of the amniotic cavity by other microorganisms, and a No-microbial invasion of the amniotic cavity/Nointra-amniotic inflammation group. The short-term neonatal outcome was evaluated in women delivering after 24.0 weeks. Results. We included 228 women with preterm labor. Microbial invasion of the amniotic cavity occurred in 35% (80/228), 28% (22/80) being caused by Ureaplasma spp. Gestational age at admission and at delivery were significantly earlier and the rate of delivery at <24.0 weeks' gestation and of women who further developed clinical chorioamnionitis were significantly higher in women with microbial invasion of the amniotic cavity by microorganisms other than Ureaplasma spp. However, after 24 weeks, regardless of the microorganisms isolated, the shortterm neonatal outcome was similar between women exposed to microbial invasion of the amniotic cavity and the No-microbial invasion of the amniotic cavity/No-intra-amniotic inflammation group when gestational age was considered. Conclusions. Microbial invasion of the amniotic cavity by microorganisms other than Ureaplasma spp. was associated with earlier gestational age at admission and at delivery, and a higher rate of preterm delivery <24.0 weeks and of women who developed clinical chorioamnionitis. However, we did not find differences in the short-term neonatal outcome between women exposed to microbial invasion of the amniotic cavity and the no-microbial invasion of the amniotic cavity/no-intra-amniotic inflammation group delivering after 24.0 weeks' gestation when adjusted by gestational age at delivery.
Introduction
One of the main clinical challenges in the management of women with preterm labor (PTL) is the detection of those who will actually deliver within a few days and whose newborns will have a worse neonatal outcome.
Microbial invasion of the amniotic cavity (MIAC) is a subclinical stage of infection involved in the etiopathology of PTL (1-6) mainly at earlier gestational ages.
The majority of bacteria and fungi that cause MIAC have an endogenous origin, the human microbiota. On one hand, genital Mycoplasmas, and specifically Ureaplasma spp., have been reported as the most frequent microorganisms isolated in amniotic fluid in the absence of clinical chorioamnionitis (4) (5) (6) . MIAC by Ureaplasma spp. has been suggested to be a chronic process that generates a progressive and stronger inflammatory response similar to that observed by microorganisms other than Ureaplasma spp (7, 8) .
On the other hand, there is growing evidence that the microbiota of the oral cavity such as Fusobacterium or Streptococcus is a source of diverse microbes causing MIAC through hematogenous dissemination (9) (10) (11) (12) .
Regardless of the type of microorganism isolated in the amniotic cavity, there is an inverse relation between microbial abundance in the amniotic fluid and gestational age; that is, the greater the amount of bacteria isolated, the earlier the gestational age at delivery in women with PTL or preterm prelabor rupture of membranes (9) . Therefore, there have been reports that women exposed to MIAC present a significantly earlier gestational age at admission and delivery, a shorter latency to delivery, and a worse neonatal outcome compared with women not exposed to MIAC (3, 5, 13) .
In newborns, an association has been observed between the inflammatory response elicited by Ureaplasma spp. and neonatal morbidity related to prematurity, such as bronchopulmonary dysplasia, intraventricular hemorrhage, and necrotizing enterocolitis (14) (15) (16) (17) (18) . Similar findings have been shown in experimental data (19, 20) . However, there are no previous studies comparing the short-term neonatal outcome according to the microorganism detected in the amniotic fluid in women with PTL (such as Ureaplasma spp.). Therefore, the aim of this study was to evaluate the impact of MIAC and the type of microorganisms isolated in the amniotic fluid on short-term neonatal outcome in women with PTL.
Material and methods
Written informed consent was obtained from all women. The Ethics Committee of Hospital Clinic of Barcelona (HCB/2005/56, HCB/2010/5811) approved this study as well as the collection and use of these samples for research purposes.
A prospective observational cohort study was performed in women with PTL (22.0-36.0 weeks' gestation) admitted to the Maternal-Fetal Medicine Department at Hospital Clinic in Barcelona from 2005 to 2014 in whom an amniocentesis was performed to rule out MIAC. Women with clinical signs of chorioamnionitis at admission, multiple gestation, preterm premature rupture of membranes (PPROM), a known cause of bleeding and in whom amniocentesis could not be performed due to technical problems were considered non-eligible for this study.
Gestational age was established according to the firsttrimester ultrasound scan.
Preterm labor was defined as the presence of regular uterine contractions with a frequency of at least two every 10 min and a cervical length measured by transvaginal ultrasound of less than 25 mm in women with PTL < 28.0 weeks; less than 20 mm between 28.0 and 31.6 weeks, and less than 15 mm > 32.0 weeks' gestation (21) .
Key Message
Microbial invasion of the amniotic cavity by microorganisms other than Ureaplasma spp. was associated with a worse pregnancy outcome than the No-microbial invasion of the amniotic cavity/No-intra-amniotic inflammation group. However, after 24.0 weeks, regardless of the microorganisms isolated, the shortterm neonatal outcome was related to an earlier gestational age at delivery.
Clinical chorioamnionitis was defined based on Gibbs criteria (22) as temperature ≥37.8°C and two or more of the following criteria: uterine tenderness, malodorous vaginal discharge, fetal tachycardia (>160 beats/min), and leukocytosis >15 000/mm 3 . Three groups of women were studied: women with MIAC by Ureaplasma spp., women with MIAC by other microorganisms, and women with neither MIAC or IAI (No-MIAC/No-IAI). Women with negative amniotic fluid cultures but with high levels of interleukin 6 (IL-6) were considered to have sterile IAI (23) and were excluded (manuscript under preparation).
Microbial invasion of the amniotic cavity was defined as a positive aerobic/anaerobic amniotic fluid culture for bacteria or yeast, or the presence of Ureaplasma spp. and Mycoplasma hominis in mycoplasma culture.
Intra-amniotic inflammation was defined when levels of amniotic fluid IL-6 were ≥13.4 ng/mL according to the receiver operating characteristic curve analysis previously employed by our group (5) and similar to that reported by Romero et al (1) .
Demographic data and pregnancy outcomes were recorded. Short-term neonatal outcome was evaluated in women delivering at more than 24.0 weeks and included the Apgar score at five minutes <7, umbilical artery pH ≤7.10, admission to the neonatal intensive care unit (NICU) and composite neonatal morbidity including the presence of any of the following criteria: (i) intraventricular hemorrhage grade III-IV diagnosed by cranial ultrasound examinations; and (ii) respiratory distress syndrome defined by the presence of two or more of the following criteria: a persistent oxygen requirement for >24 h, administration of exogenous surfactant and radiologic evidence of bilateral interstitial infiltrate, opacification of the lung fields, pathological air bronchogram or decreased lung volume; early-onset sepsis defined by clinical and analytical criteria; suspicion of periventricular leukomalacia by ultrasound; necrotizing enterocolitis defined as the radiologic finding of either intramural gas or free intraabdominal gas; retinopathy of prematurity identified using retinoscopy; fetal and neonatal death.
Maternal morbidities included endometritis, surgical wound and blood transfusion. Endometritis was defined as postpartum temperature ≥38°C on two occasions at least six hours apart, associated with one of the following symptoms: lower abdominal and pelvic pain reported spontaneously or during clinical examination, sub-involution of the uterus, persistent bleeding or malodorous lochia.
Clinical management
According to our standard clinical management, at admission we performed blood analysis including C-reactive protein (CRP) and white cell blood count (WBC), cervical length measurement by transvaginal ultrasound, and genital aerobic/anaerobic/fungal cultures.
Based on a research protocol, from 2005 to 2007 a transabdominal amniocentesis was performed to rule out MIAC before the administration of steroids or tocolysis in women with PTL <36.0 weeks. From 2008 onwards, the indication for amniocentesis was offered not only for research purposes but also as part of the clinical management in women admitted by PTL <34.0 weeks without suspicion of clinical chorioamnionitis.
A complete course of antenatal steroids (betamethasone 12-mg intramuscular injection with two doses given 24 h apart) was administered in cases with PTL between 24.0 and 34.6 weeks. Tocolysis (ritodrine, nifedipine or atosiban) was considered in the absence of clinical chorioamnionitis, MIAC, placenta abruption or non-reassuring fetal status (biophysical profile ≤4, or atypical or late decelerations of fetal heart rate). From 2011 onwards, magnesium sulfate was administered for fetal neuroprotection if labor started between 24.0 and 32.0 weeks. Our policy of neonatal resuscitation involves active management after 24.0 weeks or neonatal birthweight >500 g.
Women with a positive genital culture were treated orally or vaginally with antibiotics according to the microorganism isolated. Women with MIAC who remained undelivered at the time the results of the amniotic fluid cultures were available, were treated with parenteral antibiotics for 10 days according to the antibiogram of the microorganism isolated. Azithromycin was the antibiotic of choice in the case of MIAC by Ureaplasma spp., based on its efficacy reported in animal models and its pharmacokinetics in pregnant women (19, 24, 25) . In the case of other microorganisms, beta-lactam, gentamicin and clindamycin were the antibiotics most commonly used. Maternal and fetal status were closely monitored (including CRP, WBC, cardiotocography and ultrasound evaluation). If undelivered, induction of labor was individually indicated based on the virulence of the microorganism, non-reassuring fetal status, suspicion of clinical chorioamnionitis and gestational age.
Methods
Cultures for genital mycoplasmas (Mycoplasma IST 2; BioM erieux, Marcy l'Etoide, France) and aerobic and anaerobic bacteria (chocolate agar in aerobiosis, Schaedler agar in anaerobiosis and thioglycollate broth), as well as amniotic fluid glucose levels and Gram stains were analyzed immediately after collection and the results were available for clinical management. Amniotic fluid IL-6 levels were measured by enzyme-linked immunoassay (ELISA) (Biosource; Invitrogen, Carlsbad, CA, USA) in amniotic fluid samples previously centrifuged at 4000 g for 10 min at 4°C and stored at À80°C. The minimum detectable level of IL-6 was 0.2 ng/mL (5).
Statistical analyses
Statistical analysis was performed using SPSS 20.0 for MAC OS (IBM Corp., Armonk, NY, USA). Continuous variables were compared using a non-parametric MannWhitney U-test presented as median with interquartile range (IQR) (25th; 75th percentile or minimum-maximum). Categorical variables were compared using the chi-square or Fisher exact test and presented as numbers (%). Binary logistic regression was used to adjust amniotic fluid IL-6 levels for gestational age at admission and short-term neonatal outcomes for gestational age at delivery. Differences were considered statistically significant at p < 0.05 with two-sided alternative hypotheses.
Results
Over the study period, 720 women were admitted with a diagnosis of PTL from 22.0 to 36.0 weeks without clinical suspicion of chorioamnionitis. Of these, 307 women underwent amniocentesis to rule out MIAC. Figure 1 shows the flowchart of the study.
Demographic data and pregnancy outcomes of 228 women were available for the final analysis. The overall rate of MIAC was 35% (80/228), 28% (22/80) being caused by Ureaplasma spp. Table 1 shows the microorganisms isolated.
Seventy percent of women (56/80) with MIAC remained undelivered at the time of starting antibiotic treatment, 30% (17/56) caused by Ureaplasma spp. and 70% (39/56) by other microorganisms. Figure 2 shows the distribution of the different groups according to gestational age at admission.
We observed a higher prevalence of MIAC caused by other microorganisms at very early gestational ages. Indeed, at <28.0 weeks' gestation, 87% of MIAC (39/45) were due to microorganisms other than Ureaplasma spp. Table 2 describes demographic data and pregnancy outcomes among the three groups. As expected (1, 4, 26, 27) , the amniotic fluid IL-6 level was higher, glucose was lower and gestational age at delivery was earlier in women with MIAC regardless of the microorganism isolated. However, gestational age at admission was earlier, and maternal CRP and WBC levels, rate of preterm delivery at <24.0 weeks and the occurrence of clinical chorioamnionitis were significantly higher in the group with MIAC than other microorganisms. However, these differences were not observed between women with MIAC by Ureaplasma spp. and the No-MIAC/No-IAI group. No other significant differences were found in maternal morbidity (endometritis, wound infection, blood transfusion) among groups. Finally, the levels of amniotic fluid IL-6 were similar between MIAC by Ureaplasma spp. and MIAC by other microorganisms (p = 0.792). Table 3 and in Supporting Information Appendix S1. Although significant differences were observed between groups in the unadjusted analysis, no differences were observed in short-term outcome between women with MIAC and the No-MIAC/No-IAI group when gestational age was taken into consideration. The only effect observed was a difference in the rate of retinopathy of prematurity when comparing the group with MIAC caused by other microorganisms with the No-MIAC/No-IAI group (p = 0.043). There was one fetal death in a woman with MIAC by Listeria monocytogenes admitted at 24.3 weeks. One-third of neonatal deaths occurred at a gestational age <25.0 weeks (4/12) and the rest between 25.0 and 28.0 weeks due to postnatal complications.
On comparing the MIAC groups (Ureaplasma spp. vs. other microorganisms), we observed an earlier gestational age at admission and at delivery, and a higher rate of preterm birth <28.0 weeks in women with MIAC caused by other microorganisms. However, we did not observe significant differences in the short-term neonatal outcome between these two groups. Table 4 shows the relation between gestational age at delivery, MIAC and short-term neonatal outcome. Gestational age at delivery but not exposure to MIAC, was found to be an independent factor of short-term neonatal outcome.
Finally, detailed information about clinical management and short-term neonatal outcome according to the type of microorganism isolated (e.g. genital mycoplasma, Gram-negative bacteria, Gram-positive bacteria, anaerobe bacteria, polymicrobial infection or infection by yeasts) in newborns ≥24.0 weeks is shown in Supporting Information Appendix S2.
Discussion
In this study we found that the short-term neonatal outcome of women exposed to MIAC was related to an earlier gestational age at delivery compared with the No-MIAC/No-IAI group. However, no differences were observed between groups when gestational age was considered.
Our results suggest that gestational age at admission should be taken into account when MIAC by microorganisms other than Ureaplasma spp. is suspected. Thus, <28.0 weeks, 87% of MIAC (39/45) were caused by microorganisms other than Ureaplasma spp. Although we previously reported how the combination of an early gestational age at admission (<28 weeks) and a short cervical length (<15 mm) predicted the occurrence of MIAC with a detection rate of 84% (27) , this is the first report evaluating the influence of gestational age at admission according to the microorganism isolated in women with MIAC. Our findings highlight the importance of ruling out an infectious origin and specifically suspecting an infection by microorganisms other than Ureaplasma spp. at very early gestational ages. In addition, a higher rate of preterm delivery at <24.0 weeks and in women who finally developed clinical chorioamnionitis was observed when MIAC was caused by other microorganisms and not Ureaplasma spp., information that is useful for antenatal clinical management.
No other differences were found among groups related to maternal morbidity, probably because of the identification of MIAC in a subclinical stage without clinical signs of chorioamnionitis.
Regarding intra-amniotic inflammation in women with MIAC, amniotic fluid IL-6 did not differ between MIAC by Ureaplasma spp. or other microorganisms. Although our definition of IAI was based only on the presence of AF, amniotic fluid; CRP, C-reactive protein; GA, gestational age; IAI, intra-amniotic inflammation; IL-6, interleukin-6; MIAC, microbial invasion of the amniotic cavity; WBC, white blood cells. Continuous variables are presented as median (IQR: 25th; 75th percentile) and were compared using a nonparametric Mann-Whitney U-test. Categorical variables are presented as number (%) and were compared using chi-square test or Fisher exact test. high IL-6 levels and we did not explore the inflammatory response elicited by other biomarkers, there are no previous studies evaluating the influence of microorganisms (Ureaplasma spp. vs. other microorganisms) on the amniotic IL-6 levels in women with PTL, with the only references being reported in women with PPROM (28, 29) . As expected (1, 3, 4, 27) , gestational age at delivery was significantly earlier in women with MIAC than in the No-MIAC/No-IAI group. In addition, women with MIAC by microorganisms other than Ureaplasma spp. delivered significantly earlier than did women with MIAC by Ureaplasma spp. However, after adjusting the short-term neonatal outcome for gestational age at delivery, we did not find significant differences except for a higher rate of retinopathy of prematurity when MIAC was caused by other microorganisms (p = 0.043). In this regard, our data are in line with a previously reported association between factors such as placental infection and inflammation and retinopathy of prematurity (30) (31) (32) ; our paper is the first report that shows an association with MIAC caused by other microorganisms.
Our findings are in line with those of a previous study by our group in women with PPROM (8) and those reported by others in PTL (33) , highlighting that gestational age at delivery is more important for the shortterm neonatal outcome compared with MIAC in women with PTL without suspicion of clinical chorioamnionitis.
Systematic prophylactic treatment with antibiotics in PTL is not standard care management. It has not shown any benefit on short-term outcome (34) and has even been associated with a higher risk of cerebral palsy at seven years of follow up (35) . Our data provide unique information about the short-term neonatal outcome when an amniocentesis and targeted treatment are integrated into the clinical management of women with PTL. To our knowledge, the only references related to targeted treatment describe an experimental model with rhesus monkeys infected by Ureaplasma parvum in which a longer latency to delivery, a lower inflammatory response and a significantly lower presence of the microorganism in the amniotic fluid and the umbilical cord was observed in monkeys treated with azithromycin (19, 36) .
The main strength of this study is that the short-term neonatal outcome regarding the presence of MIAC and the type of microorganisms isolated in the amniotic fluid has been compared with a no-MIAC/No-IAI group in a large prospective cohort of women with PTL without suspicion of clinical chorioamnionitis. In addition, our prevalence of MIAC in women with PTL was much higher (35%) than previously reported (3, 4) , probably due to the strict criteria of admission we followed in women with PTL, selecting only those with "true" labor (21) . Finally, to avoid the contribution of IAI, sterile IAI (negative amniotic fluid culture with high IL-6 levels) was excluded. Nevertheless, our study has some limitations. First, we did not perform genomic non-cultivation technologies (23) and therefore we probably under-diagnosed the proportion of women with MIAC. However, to date, amniotic fluid cultures continue to be the "gold standard" to define MIAC in most clinical settings. Secondly, a comparison between women with MIAC treated or not with antibiotics was not possible because all undelivered women with MIAC were treated. We acknowledge that this approach limits the evaluation of the benefit on the short-term neonatal outcome of the performance of an amniocentesis and the targeted treatment. What impact the clinical management (e.g. use of antenatal steroids) and the presence of MIAC had on the long-term outcome was not evaluated, but this was not the aim of the study. Finally, although the prevalence of MIAC in our study was higher than previously reported by other authors, we acknowledge this was a unicenter study with an observational design limiting sample size among groups. Further multicenter studies may be planned to validate our findings.
In conclusion, microorganisms other than Ureaplasma spp. were associated with an earlier gestational age at admission and at delivery, and a higher risk to further develop clinical chorioamnionitis. The short-term neonatal outcome of women exposed to MIAC was related to an earlier gestational age at delivery when compared with the No-MIAC/No-IAI group. However, no differences were observed between groups except for a higher risk of retinopathy of prematurity when MIAC was caused by other microorganisms when gestational age at delivery was considered. This information may be useful in the antenatal management of these women and for neonatologists in the immediate postnatal period. 
